The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: Results of the continuous electrocardiographic assessment substudy

Journal of the American College of Cardiology

Volumn 57, Issue 19, 2011, Pages 1908-1916

  Scirica, Benjamin M ^a   Cannon, Christopher P ^a   Emanuelsson, Hkan ^b   Michelson, Eric L ^c   Harrington, Robert A ^d   Husted, Steen ^e   James, Stefan ^f   Katus, Hugo ^g   Pais, Prem ^h   Raev, Dimitar ⁱ   Spinar, Jindrich ^j   Steg, Ph Gabriel ^k,l,m   Storey, Robert F ⁿ   Wallentin, Lars ^f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ASTRAZENECA R AND D   (Sweden)

^c ASTRAZENECA   (United Kingdom)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f UPPSALA UNIVERSITY   (Sweden)

^g UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^h ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

ⁱ Ministry of Interior   (Bulgaria)

^j MASARYK UNIVERSITY   (Czech Republic)

^k INSERM   (France)

^l UNIVERSITÉ PARIS DESCARTES   (France)

^m BICHAT HOSPITAL   (France)

ⁿ UNIVERSITY OF SHEFFIELD   (United Kingdom)

more..

Author keywords

acute coronary syndrome; bradycardia; ticagrelor

Indexed keywords

CLOPIDOGREL; TICAGRELOR;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BRADYCARDIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; ELECTROCARDIOGRAPHY; FEMALE; HEART ARREST; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PACEMAKER FAILURE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SINUS NODE; SYNCOPE; THROMBOCYTE AGGREGATION INHIBITION;

ACUTE CORONARY SYNDROME; ADENOSINE; AGED; BRADYCARDIA; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955590021     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.11.056     Document Type: Article

References (12)

1. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
2. C.P. Cannon, S. Husted, and R.A. Harrington Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial J Am Coll Cardiol 50 2007 1844 1851 (Pubitemid 350007959)
3. 12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: rationale, design, and baseline characteristics of the Platelet Inhibition and Patient Outcomes (PLATO) trial Am Heart J 157 2009 599 605
4. A.E. Epstein, J.P. DiMarco, and K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) J Am Coll Cardiol 51 2008 e1 e62
5. D.P. Zipes, A.J. Camm, and M. Borggrefe ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J Am Coll Cardiol 48 2006 e247 e346
6. R.F. Storey, S. Husted, and R.A. Harrington Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes J Am Coll Cardiol 50 2007 1852 1856 (Pubitemid 350017792)
7. J.-A. Bjrkman, I. Kirk, and J.J. van Giezen AZD6140 inhibits adenosine uptake into erythrocytes and enhances coronary blood flow after local ischemia or intracoronary adenosine infusion (abstr) Circulation 116 2007 II28
8. K. Wang, X. Zhou, and Y. Huang Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model Thromb Haemost 104 2010 609 617
9. L. Belardinelli, and B.B. Lerman Adenosine: cardiac electrophysiology Pacing Clin Electrophysiol 14 1991 1672 1680
10. J.P. Headrick, B. Hack, and K.J. Ashton Acute adenosinergic cardioprotection in ischemic-reperfused hearts Am J Physiol Heart Circ Physiol 285 2003 H1797 H1818
11. J.T. Bigger Jr., J. Coromilas, L.M. Rolnitzky, J.L. Fleiss, R.E. Kleiger Multicenter Diltiazem Postinfarction Trial Investigators Effect of diltiazem on cardiac rate and rhythm after myocardial infarction Am J Cardiol 65 1990 539 546 (Pubitemid 20091877)
12. B.M. Scirica, D.A. Morrow, and H. Hod Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial Circulation 116 2007 1647 1652 (Pubitemid 47537839)